Document is current
Any future updates will be listed below
-
Authors
Sheerin, Dylan http://orcid.org/0000-0001-9456-5712
Dold, Christina
Silva-Reyes, Laura
Linder, Aline
Pollard, Andrew J.
Rollier, Christine S.
-
Funding
Funding for this research was provided by:
Medical Research Council
National Institute for Health Research
BactiVac (BVNCP-19)
- License Information
-
More Information
Article History
Received: 14 December 2021
Accepted: 9 May 2022
First Online: 11 June 2022
Declarations
:
: All procedures were performed in accordance with the terms of the UK Home Office Animals Act Project License. Procedures were approved by the University of Oxford Animal Care and Ethical Review Committee. The study was carried out in compliance with the ARRIVE guidelines [CitationRef removed]. No human samples were used in the study.
: Not applicable.
: A.J.P. is Chair of UK Dept. Health and Social Care’s (DHSC) Joint Committee on Vaccination & Immunisation (JCVI) and is a member of the WHO’s SAGE. The views expressed in this article do not necessarily represent the views of DHSC, JCVI, NIHR or WHO. The University of Oxford has entered into a partnership with AstraZeneca on coronavirus vaccine development. C.S.R., C.D., D.S., and A.J.P. are named inventors on a patent application in the field of meningococcal vaccine. A.J.P waives all his rights to any patent.
